Cessatech A/S
Public limited companyCVR 41293055HellerupActive
Cessatech A/S is a public limited company, based in Hellerup, active in manufacture of pharmaceutical preparations, founded in 2020. The company made a loss in both 2024 and 2025, most recently DKK 10.9m. Equity grew to DKK 12.2m in 2025. 8 other companies in the database are registered at the same address.
Key figures · financial year 2025
What has changed
calculated from recorded figures and datesFinancials: 2025 against 2024
- Revenue rose 130% (2024 → 2025), to DKK 5.7m.
- The loss got smaller: from DKK 14.7m to DKK 10.9m (2024 → 2025).
- Equity rose 47% (2024 → 2025), to DKK 12.2m.
Management and owners, last 24 months
- New in management: Martin Juhl (director, 19/06/2025).
- Stepped down: Anders Dyhr Dombernowsky-Toft (board member, 28/03/2025).
- New owners registered: Jes Trygved (28/05/2025).
- No longer registered as owner: Jes Trygved (27/05/2025).
Registrations, last 24 months
- 04/06/2025: Share capital changed from 3,485,019 DKK to 3,715,287 DKK
Calculated from the latest two annual reports in sequence and from registrations in CVR. A figure that is missing in either year gives no line, and we derive no figures.
Financial statements
Financial years 2020–2025 · amounts in DKK thousandEquity and net profit
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | Change | |
|---|---|---|---|---|---|---|---|
| Revenue | not stated | not stated | 0 | 0 | 2,486 | 5,718 | +130% |
| Operating profit (EBIT) | −901 | −13,833 | −17,589 | −22,510 | −19,053 | −14,967 | +21.4% |
| Profit before tax | −909 | −13,893 | −17,799 | −30,740 | −17,718 | −14,969 | +15.5% |
| Net profit | −849 | −11,569 | −14,656 | −26,527 | −14,670 | −10,904 | +25.7% |
| Total assets | – | 30,653 | 28,187 | 8,504 | 15,900 | 13,389 | −15.8% |
| Equity | 13,611 | 26,242 | 23,855 | −1,919 | 8,274 | 12,156 | +46.9% |
| Liabilities | 197 | 4,411 | 4,332 | 10,423 | 7,626 | 1,233 | −83.8% |
Source: annual reports filed with the Danish Business Authority (XBRL). Figures for the company (not the group); change is the latest year against the year before. “–” means the figure is not stated in the annual report. Revenue is not stated for 2020, 2021: smaller companies may omit it, and we do not derive it from other figures.
Download the figures as CSV · free with an account, amounts in whole DKK
Signals from the financial statements
calculated from the 2025 figuresLoss for 6 years in a row
Net result has been negative in 2020–2025.
How is this calculated?
Net result is negative in the two or more latest annual reports in a row.
The signals are rules applied to the figures in the annual reports. They are not an assessment or credit rating of the company. See Data and method.
Annual reports
6 financial years| Financial year | Period | Published | Figures for | Documents |
|---|---|---|---|---|
| 2025 | 01/01/2025 – 31/12/2025 | 22/04/2026 | The company | PDF not statedXBRL |
| 2024 | 01/01/2024 – 31/12/2024 | 10/04/2025 | The company | PDF not statedXBRL |
| 2023 | 01/01/2023 – 31/12/2023 | 10/04/2024 | The company | PDF not statedXBRL |
| 2022 | 01/01/2022 – 31/12/2022 | 27/04/2023 | The company | PDF not statedXBRL |
| 2021 | 01/01/2021 – 31/12/2021 | 27/04/2022 | The company | PDF not statedXBRL |
| 2020 | 15/04/2020 – 31/12/2020 | 04/05/2021 | The company | PDF not statedXBRL |
The figures from all the annual reports are shown on this page. The documents themselves (PDF and XBRL, the machine-readable edition) are downloaded with a Pro account: sign in or create a free account, and then choose Pro. XBRL is the edition the figures on the page are read from.
Employees
monthly figures from CVRPosition in the industry
59 companies in the databaseComparison with the other companies in manufacture of pharmaceutical preparations based on the latest financial year.
Industry median: gross profit DKK 2.8m, net profit −DKK 2.2m, equity DKK 5.2m, 10 employees.
Compared with similar companies
size, age and company form| Group | Gross profit | Equity |
|---|---|---|
| Companies with fewer than 20 employees69,967 companies in the comparison | not stated | No. 7,970of 69,964 Better than 89% |
| Same industry and fewer than 20 employees37 companies in the comparison | not stated | No. 9of 37 Better than 78% |
| Companies that are between 5 and 14 years old33,688 companies in the comparison | not stated | No. 3,272of 33,687 Better than 90% |
| All companies of type A/S18,025 companies in the comparison | not stated | No. 7,984of 18,024 Better than 56% |
The rank is calculated among companies in the database with a figure for the latest financial year, and is shown only for groups of at least ten companies.
Compare with the industry
Manufacture of pharmaceutical preparations- Cessatech A/S–
- Novo Nordisk A/SDKK 250.3bn
- H. Lundbeck A/SDKK 20.4bn
- Cessatech A/S−DKK 10.9m
- Novo Nordisk A/SDKK 102.4bn
- H. Lundbeck A/SDKK 3.2bn
- Cessatech A/SDKK 12.2m
- Novo Nordisk A/SDKK 194bn
- H. Lundbeck A/SDKK 24.9bn
- Cessatech A/S3
- Novo Nordisk A/S27,279
- H. Lundbeck A/S2,261
Latest financial year per company. Choose up to three companies from the largest in the industry.
Owners and group
from the Public Ownership Register- Jes Trygved5%
Management
6 active registrationsExecutive management
| Name | Role | Appointed |
|---|---|---|
| Jes Trygved | CEO | 15/04/2020 |
| Martin Juhl | Director | 19/06/2025 |
Board of directors
| Name | Role | Appointed |
|---|---|---|
| Flemming Steen Jensen | Board member | 18/08/2020 |
| Charlotte Videbæk | Board member | 18/08/2020 |
| Rachel Verity Curtis Gravesen | Board member | 17/03/2022 |
| Martin Olin | Chair of the board | 23/03/2023 |
- Founders
- Jes Trygved, Bettina Nygaard Nielsen, Steen Winther Henneberg, Buhl Krone Holding ApS
Former management (9)
| Name | Role | Appointed | Resigned |
|---|---|---|---|
| Ulla Hald Buhl | Chair of the board | 15/04/2020 | 28/06/2021 |
| Adam Sinding Steensberg | Board member | 18/08/2020 | 28/06/2021 |
| Martin Olin | Board member | 18/08/2020 | 16/03/2022 |
| Peter Birk Rasmussen | Board member | 18/08/2020 | 05/07/2024 |
| Adam Sinding Steensberg | Chair of the board | 29/06/2021 | 22/03/2023 |
| Ulla Hald Buhl | Board member | 29/06/2021 | 06/01/2022 |
| Martin Olin | Deputy chair | 17/03/2022 | 22/03/2023 |
| Adam Sinding Steensberg | Board member | 23/03/2023 | 27/03/2024 |
| Anders Dyhr Dombernowsky-Toft | Board member | 05/07/2024 | 28/03/2025 |
Signing rule: Selskabet tegnes af bestyrelsesformanden og en direktør i forening eller af den samlede bestyrelse
Address and production units
1 active production unitsStrandvejen 60
2900 Hellerup
Gentofte Municipality · Postcode 2900
Other companies at the address (8)
- Oterra A/SManufacture of dyes and pigments
- Inspicos P/SPatent agencies and marketing-related services
- Hnet ApSComputer programming activities
- Intuitive Surgical ApSComputer consultancy and computer facilities management
- Dassault Systemes ApSComputer consultancy and computer facilities management
| Production unit | Address | Employees | P number |
|---|---|---|---|
| Cessatech A/S | Strandvejen 60, 2900 Hellerup | 5 | 1025735060 |
Purpose
Selskabets formål at udvikle dokumenteret medicin til humant brug med hoved- fokus på børn samt al virksomhed, som efter bestyrelsens skøn har forbindelse hermed.
The purpose is quoted from the register in Danish.
Changes year by year
59 registered events20261 changeaccounts 1
- AccountsAnnual report for 2025 published
20256 changesmanagement 2 · capital 1 · ownership 2 · accounts 1
- ManagementMartin Juhl appointed director
- CapitalShare capital changed from 3,485,019 DKK to 3,715,287 DKK
- OwnershipJes Trygved registered as owner (5%)
- OwnershipJes Trygved is no longer registered as owner
- AccountsAnnual report for 2024 published
- ManagementAnders Dyhr Dombernowsky-Toft stepped down as board member
20246 changesaddress 1 · management 3 · accounts 1 · capital 1
- AddressMoved to Strandvejen 60, 2900 Hellerup
- ManagementAnders Dyhr Dombernowsky-Toft appointed board member
- ManagementPeter Birk Rasmussen stepped down as board member
- AccountsAnnual report for 2023 published
- ManagementAdam Sinding Steensberg stepped down as board member
- CapitalShare capital changed from 2,757,751 DKK to 3,485,019 DKK
20235 changesaccounts 1 · management 4
- AccountsAnnual report for 2022 published
- ManagementAdam Sinding Steensberg appointed board member
- ManagementMartin Olin appointed chair of the board
- ManagementMartin Olin stepped down as deputy chair
- ManagementAdam Sinding Steensberg stepped down as chair of the board
202210 changescapital 2 · ownership 3 · accounts 1 · management 4
- CapitalShare capital changed from 2,689,501 DKK to 2,757,751 DKK
- CapitalShare capital changed from 1,222,507 DKK to 2,689,501 DKK
- OwnershipBettina Nygaard Nielsen is no longer registered as owner
- OwnershipSteen Winther Henneberg is no longer registered as owner
- AccountsAnnual report for 2021 published
- ManagementRachel Verity Curtis Gravesen appointed board member
- ManagementMartin Olin appointed deputy chair
- ManagementMartin Olin stepped down as board member
- OwnershipBUHL KRONE HOLDING ApS is no longer registered as owner
- ManagementUlla Hald Buhl stepped down as board member
20216 changescapital 1 · management 4 · accounts 1
- CapitalShare capital changed from 736,000 DKK to 1,222,507 DKK
- ManagementUlla Hald Buhl appointed board member
- ManagementAdam Sinding Steensberg appointed chair of the board
- ManagementAdam Sinding Steensberg stepped down as board member
- ManagementUlla Hald Buhl stepped down as chair of the board
- AccountsAnnual report for 2020 published
202025 changesaddress 1 · capital 2 · ownership 12 · name 1 · management 7 · status 1 · founded 1
- AddressMoved to Kanonbådsvej 2, 1437 København K
- CapitalShare capital changed from 400,000 DKK to 736,000 DKK
- OwnershipJes Trygved registered as owner (10%)
- OwnershipBettina Nygaard Nielsen registered as owner (10%)
- OwnershipSteen Winther Henneberg registered as owner (10%)
- OwnershipBUHL KRONE HOLDING ApS registered as owner (10%)
- OwnershipBettina Nygaard Nielsen is no longer registered as owner
- OwnershipSteen Winther Henneberg is no longer registered as owner
- OwnershipBUHL KRONE HOLDING ApS is no longer registered as owner
- OwnershipJes Trygved is no longer registered as owner
- NameName changed from Cessatech Aps to Cessatech A/S
- CapitalShare capital changed from 40,000 DKK to 400,000 DKK
- ManagementPeter Birk Rasmussen appointed board member
- ManagementMartin Olin appointed board member
- ManagementFlemming Steen Jensen appointed board member
- ManagementCharlotte Videbæk appointed board member
- ManagementAdam Sinding Steensberg appointed board member
- StatusStatus changed to active
- ManagementUlla Hald Buhl appointed chair of the board
- ManagementJes Trygved appointed ceo
- OwnershipBettina Nygaard Nielsen registered as owner (25%)
- OwnershipSteen Winther Henneberg registered as owner (25%)
- OwnershipBUHL KRONE HOLDING ApS registered as owner (25%)
- OwnershipJes Trygved registered as owner (25%)
- FoundedRegistered as Cessatech Aps
Related companies
Same industry in Gentofte
- Bavarian Nordic A/S1,081 employees
- Ascendis Pharma A/S688 employees
Same people in management
- Alk-abelló A/Svia Flemming Steen Jensen
- Ascendis Pharma A/Svia Martin Olin
- Zealand Pharma A/Svia Adam Sinding Steensberg
- Servier Symphogen A/Svia Martin Olin
- Sophion Bioscience A/Svia Martin Olin
- Rsp Systems A/Svia Martin Olin
Largest in the industry
- Novo Nordisk A/SDKK 250.3bn
- H. Lundbeck A/SDKK 20.4bn
- Leo Pharma A/SDKK 8.2bn
- Alk-abelló A/SDKK 4.2bn
- Bavarian Nordic A/SDKK 3bn
- Pharmacosmos A/SDKK 1.6bn
Source and updates
The information comes from the Danish Central Business Register (Danish Business Authority) and from annual reports filed with the Danish Business Authority. Last synchronised 24/10/2026. The company is protected against advertising; contact details are not shown, and the data must not be used for marketing.